Dean, Brian

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 1,178

Epigenetic aging in major depressive disorder

Han, L. K. M., Aghajani, M., Clark, S. L., Chan, R. F., Hattab, M. W., Shabalin, A. A., Zhao, M., Kumar, G., Xie, L. Y., Jansen, R., et al. (2018) · American Journal of Psychiatry

Epigenetics and DNA MethylationTreatment of Major Depression

Cited by 260

Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology

Fornito, A., Yucel, M., Dean, B., Wood, S. J., & Pantelis, C. (2009) · Schizophrenia Bulletin

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 259

Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia

Torkamani, A., Dean, B., Schork, N. J., & Thomas, E. A. (2010) · Genome Research

Schizophrenia research and treatmentBioinformatics and Genomic Networks

Cited by 134

Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation

Gray, L., van den Buuse, M., Scarr, E., Dean, B., & Hannan, A. J. (2009) · The International Journal of Neuropsychopharmacology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 130

Altered Hippocampal Muscarinic M4, but Not M1, Receptor Expression from Subjects with Schizophrenia

Scarr, E., Sundram, S., Keriakous, D., & Dean, B. (2007) · Biological Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 108

SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects

Lepagnol-Bestel, A.-M., Maussion, G., Boda, B., Cardona, A., Iwayama, Y., Delezoide, A.-L., Moalic, J.-M., Muller, D., Dean, B., Yoshikawa, T., et al. (2008) · Molecular Psychiatry

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Cited by 93

Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samples

Aberg, K. A., Dean, B., Shabalin, A. A., Chan, R. F., Han, L. K. M., Zhao, M., van Grootheest, G., Xie, L. Y., Milaneschi, Y., Clark, S. L., et al. (2020) · Molecular Psychiatry

Epigenetics and DNA MethylationGenetic Associations and Epidemiology

Cited by 73

Evaluation of Treatment in 35 Cases of Bipolar Suicide

Keks, N. A., Hill, C., Sundram, S., Graham, A., Bellingham, K., Dean, B., Opeskin, K., Dorissa, A., & Copolov, D. L. (2009) · Australian & New Zealand Journal of Psychiatry

Bipolar Disorder and TreatmentSuicide and Self-Harm Studies

Cited by 50

Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study

Scarr, E., Money, T. T., Pavey, G., Neo, J., & Dean, B. (2012) · BMC Psychiatry

Neuropeptides and Animal PhysiologySuicide and Self-Harm Studies

Cited by 28

Possible Involvement of Muscarinic Receptors in Psychiatric Disorders: A Focus on Schizophrenia and Mood Disorders

Dean, B., & Scarr, E. (2015) · Current Molecular Medicine

Receptor Mechanisms and SignalingSchizophrenia research and treatment

Cited by 19